How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
- 9 results
- Evidence type
- Clinical Area
Use check boxes to select individual results below
SmartSearch availableTrip's SmartSearch engine has discovered connected searches & results. Click to show
3. Pembrolizumab (Keytruda) - As monotherapy or in combination with platinum and 5-fluorouracil (5-FU) chemotherapy, is indicated for the first-line treatment of metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) in adults who
4. Caplacizumab (Cablivi) - For the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP), in conjunction with plasma exchange and immunosuppression.
7. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update Full Text available with Trip Pro
8. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data Full Text available with Trip Pro
To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>